{"id":3750,"company":{"country":"US","currency":"USD","exchange":"NEW YORK STOCK EXCHANGE, INC.","ipo":"1961-05-15","marketCap":17957.6,"name":"Baxter International Inc","phone":"18479482000","outstanding":509.35,"symbol":"BAX","website":"https://www.baxter.com/","industry":"Health Care"},"price":32.935,"year":2024,"month":6,"day":11,"weekday":"Tuesday","title":"Historical Price-to-Earnings (P/E) Ratio Trends of Baxter International Inc","date":"2024-06-11","url":"/posts/2024/06/11/BAX","content":[{"section":"What is the Price-to-Earnings (P/E) Ratio?","text":"The price-to-earnings (P/E) ratio is a financial metric used to assess the valuation of a company's stock. It is calculated by dividing the market price per share by the earnings per share (EPS) of the company. The P/E ratio indicates how much investors are willing to pay for each dollar of earnings generated by the company."},{"section":"Importance of P/E Ratio for Investors","text":"The P/E ratio is an important tool for investors as it provides insight into the market's expectations for a company's future earnings growth. A higher P/E ratio suggests that investors have higher expectations for future earnings growth, while a lower P/E ratio may indicate lower expectations or undervaluation. It allows investors to compare the relative valuation of a stock with its industry peers and the overall market."},{"section":"Analysis of Baxter International Inc's Historical P/E Ratio Trends","text":"Here is a summary of Baxter International Inc's historical P/E ratio trends:"},{"section":"Year","text":"P/E Ratio"},{"section":"2015","text":"14.21"},{"section":"2016","text":"14.44"},{"section":"2017","text":"25.68"},{"section":"2018","text":"19.34"},{"section":"2019","text":"24.96"},{"section":"2020","text":"20.07"},{"section":"2021","text":"27.89"},{"section":"Significance for Investors","text":"The historical P/E ratio trends of Baxter International Inc stock reveal the following insights for investors:\n\n1. In 2015 and 2016, the P/E ratio remained relatively stable around 14-15, indicating moderate market expectations for earnings growth.\n\n2. In 2017, the P/E ratio increased significantly to 25.68, suggesting higher investor expectations for future earnings growth.\n\n3. The P/E ratio decreased in 2018 to 19.34, possibly due to a slowdown in earnings growth or a correction in stock valuation.\n\n4. In 2019, the P/E ratio increased again to 24.96, indicating renewed investor optimism about future earnings.\n\n5. The P/E ratio for 2020 and 2021 continues to show higher valuations, reaching 20.07 and 27.89, respectively. This suggests that investors have continued to have high expectations for earnings growth.\n\nOverall, investors should consider the historical P/E ratio trends along with other fundamental and qualitative factors before making investment decisions."}],"tags":["OverSold","Long","Health Care"],"news":[{"category":"company","date":1718082982,"headline":"Fitch Affirms and Withdraws Baxter's Ratings","id":128194744,"image":"","symbol":"BAX","publisher":"Finnhub","summary":"Fitch Ratings has affirmed and subsequently withdrawn Baxter International Inc. and Baxter Healthcare SA's Long-Term Issuer Default Ratings and senior unsecured instrument ratings at 'BBB-', and...","url":"https://finnhub.io/api/news?id=6b2ccc63fed79fbd0f0d3b08979d4a0e55549ec03b5dfd894e7310c9b7ba61aa"},{"category":"company","date":1718026810,"headline":"Here's Why Baxter International (BAX) is a Strong Value Stock","id":128190186,"image":"https://media.zenfs.com/en/zacks.com/f541c90e0d995722d10914cb76a7c653","symbol":"BAX","publisher":"Yahoo","summary":"Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.","url":"https://finance.yahoo.com/news/heres-why-baxter-international-bax-134010582.html"},{"category":"company","date":1717759080,"headline":"How Is The Market Feeling About Baxter Intl?","id":128141949,"image":"","symbol":"BAX","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3531136912"},{"category":"company","date":1717752240,"headline":"Baxter participates in a conference call with JPMorgan","id":128141951,"image":"","symbol":"BAX","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3531008538"},{"category":"company","date":1717704900,"headline":"Baxter to Present at Goldman Sachs 45th Annual Global Healthcare Conference","id":128131930,"image":"https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png","symbol":"BAX","publisher":"Yahoo","summary":"DEERFIELD, Ill., June 06, 2024--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Goldman Sachs 45th Annual Global Healthcare Conference on Wednesday, June 12, 2024. Joel Grade, Baxter’s chief financial officer, is scheduled to present at 8:40 a.m. Eastern Time.","url":"https://finance.yahoo.com/news/baxter-present-goldman-sachs-45th-201500235.html"},{"category":"company","date":1717664400,"headline":"Nuwellis and DaVita Extend Supply and Collaboration Agreement Pilot Phase","id":128123483,"image":"","symbol":"BAX","publisher":"GlobeNewswire","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=9l4dwlhac8"},{"category":"company","date":1717583880,"headline":"Baxter International is Oversold","id":128102939,"image":"","symbol":"BAX","publisher":"Dividend Channel","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3527632882"},{"category":"company","date":1717582980,"headline":"The most crowded longs and shorts in U.S. Med-Tech for May - UBS","id":128092735,"image":"","symbol":"BAX","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3527614274"},{"category":"company","date":1717564860,"headline":"7 Deeply Undervalued Stocks to Buy Now or Regret Later","id":128091850,"image":"","symbol":"BAX","publisher":"InvestorPlace","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3527281462"},{"category":"company","date":1717232400,"headline":"5 Relatively Secure And Cheap Dividend Stocks To Invest In - June 2024","id":128027562,"image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1249993252/image_1249993252.jpg?io=getty-c-w1536","symbol":"BAX","publisher":"SeekingAlpha","summary":"See five large-cap dividend-paying companies trading at a significant discount to their historical norms. Click for our full monthly update of dividend picks.","url":"https://seekingalpha.com/article/4696273-5-relatively-secure-and-cheap-dividend-stocks-to-invest-in-june-2024"},{"category":"company","date":1717149360,"headline":"BAX July 12th Options Begin Trading","id":128014010,"image":"","symbol":"BAX","publisher":"Stock Options Channel","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3520628135"},{"category":"company","date":1717128840,"headline":"Baxter International Inc. stock outperforms competitors on strong trading day","id":128014012,"image":"","symbol":"BAX","publisher":"MarketWatch","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3521134043"},{"category":"company","date":1717096994,"headline":"Baxter International (NYSE:BAX) Has Announced A Dividend Of $0.29","id":127994134,"image":"https://media.zenfs.com/en/simply_wall_st__316/b23fe2923663ce315e2ef7ba313db8b9","symbol":"BAX","publisher":"Yahoo","summary":"The board of Baxter International Inc. ( NYSE:BAX ) has announced that it will pay a dividend of $0.29 per share on the...","url":"https://finance.yahoo.com/news/baxter-international-nyse-bax-announced-192314935.html"},{"category":"company","date":1717093515,"headline":"Goldman Sachs Initiates Coverage of Baxter International (BAX) with Neutral Recommendation","id":127978532,"image":"","symbol":"BAX","publisher":"Fintel","summary":"","url":"https://fintel.io/news/goldman-sachs-initiates-coverage-of-baxter-international-bax-with-neutral-recommendation-206"},{"category":"company","date":1717066114,"headline":"New Cohort Study Data Shows Baxter's Expanded Hemodialysis, Known as HDx Therapy is associated with approximately 25% Lower Mortality Rate for up to Four Years","id":127973212,"image":"","symbol":"BAX","publisher":"Finnhub","summary":"DEERFIELD - Baxter International Inc. , a global innovator in kidney care and vital organ support, today announced new data showing expanded hemodialysis, known as HDx therapy, enabled by Theranova...","url":"https://finnhub.io/api/news?id=19bd7810eb41e1db2837c85dea13adc91062db7abcf217cc49e649172d3ec432"},{"category":"company","date":1717059600,"headline":"PayPal upgraded, UiPath downgraded: Wall Street's top analyst calls","id":127974307,"image":"","symbol":"BAX","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3518689252"},{"category":"company","date":1717052640,"headline":"Unveiling 5 Analyst Insights On Baxter Intl","id":127977126,"image":"","symbol":"BAX","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3518542574"},{"category":"company","date":1717041120,"headline":"Baxter initiated with neutral view at Goldman Sachs, here's why","id":127977128,"image":"","symbol":"BAX","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3518363886"},{"category":"company","date":1717040220,"headline":"Baxter International Moves Up In Market Cap Rank, Passing Verisign","id":128014013,"image":"","symbol":"BAX","publisher":"The Online Investor","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3519277465"},{"category":"company","date":1717039620,"headline":"Baxter International: A Balanced Outlook with Growth Potential and Financial Caution","id":127977129,"image":"","symbol":"BAX","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3518344444"},{"category":"company","date":1716986700,"headline":"New Cohort Study Data Shows Baxter’s Expanded Hemodialysis – Known as HDx Therapy – Is Associated With Approximately 25% Lower Mortality Rate for up to Four Years","id":127963652,"image":"https://media.zenfs.com/en/business-wire.com/4c1db18a0b8abceccf797cc430f5399c","symbol":"BAX","publisher":"Yahoo","summary":"DEERFIELD, Ill., May 29, 2024--Baxter International Inc. (NYSE:BAX), a global innovator in kidney care and vital organ support, today announced new data showing expanded hemodialysis, known as HDx therapy, enabled by Theranova dialyzer, was associated with an approximately 25% lower all-cause mortality risk for up to four years when compared to high-flux hemodialysis (HF HD). The study, \"Survival of expanded hemodialysis and high-flux hemodialysis patients in Colombia: a cohort study,\" was prese","url":"https://finance.yahoo.com/news/cohort-study-data-shows-baxter-124500229.html"},{"category":"company","date":1716980580,"headline":"Reasons to Retain Baxter International (BAX) in Your Portfolio Now","id":127963653,"image":"https://media.zenfs.com/en/zacks.com/9c7450ec9df154559fbeb393640d6629","symbol":"BAX","publisher":"Yahoo","summary":"Baxter International's (BAX) robust growth across all geographies, along with transformational initiatives, boosts confidence. However, pandemic-related disruption continues to hurt sales.","url":"https://finance.yahoo.com/news/reasons-retain-baxter-international-bax-110300978.html"},{"category":"company","date":1716978000,"headline":"Ex-Dividend Reminder: Baxter International, EPR Properties and Kinsale Capital Group","id":127956209,"image":"","symbol":"BAX","publisher":"Dividend Channel","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3517045923"},{"category":"company","date":1716969000,"headline":"Baxter: HDx therapy data show 25% lower mortality rate up to four years","id":127956211,"image":"","symbol":"BAX","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3516866261"}]}